Reuters logo
BRIEF-Caladrius Biosciences Q2 loss per share $0.22 from continuing operations
2017年8月10日 / 晚上8点20分 / 2 个月前

BRIEF-Caladrius Biosciences Q2 loss per share $0.22 from continuing operations

Aug 10 (Reuters) - Caladrius Biosciences Inc

* Caladrius Biosciences reports 2017 second quarter results

* Q2 loss per share $0.22 from continuing operations Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below